Navigation Links
Premier Research Names Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety
Date:5/28/2008

PHILADELPHIA, May 28 /PRNewswire/ -- Premier Research Group plc (AIM: PRG), the international pharmaceutical services group, announces the appointment of Anthony Faragasso, MD as Executive Director and Global Head of Medical Management and Safety. In this position, Dr. Faragasso will lead the global Medical Management and Safety team ensuring the delivery of quality medical and safety services

Dr. Faragasso brings to Premier Research a wealth of experience in global safety monitoring, post marketing surveillance, and risk management planning. He started his pharmaceutical career in Ortho Pharmaceutical Corp. in 1985 after completing his medical degree and fellowship training in infectious diseases. Since then he held positions with increasing responsibilities in pharmaceutical companies and CROs including: Rhone Poulenc Rorer Central Research; Synergen, Inc.; Centocor, Inc.; OmniCare (formerly IBAH-BioPharm); Pharmacia-Upjohn, and MDS Pharma Services. Dr. Faragasso comes to Premier Research from Adolor Corporation where he established and managed a successful and growing safety department over the last 7 years.

"We are very pleased to have Dr. Faragasso join our Medical Affairs Department in this important role," said Dr. Kaba, Vice President, Global Medical Affairs and Strategic Product Development. "His expertise and proven leadership will strengthen our team and help us expand our medical and safety services to meet the evolving needs of our clients."

About Premier Research

Premier Research is a leading solutions-driven CRO leveraging their commitment to therapeutic focus and scientific expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for Analgesia, CNS, Infectious Disease, and Oncology and have a wealth of experience in medical device and pediatric research. Premier Research has 29 offices and operates in more than 30 countries across Europe and North America. They employ a strong international network of monitors and project management professionals combined with regulatory, data management, statistical, scientific and medical experts, and staff at a well-established network of dedicated clinical sites.

http://www.premier-research.com


'/>"/>
SOURCE Premier Research Group plc
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
2. Five Medical Technology Companies Host Premier Event for Cardiothoracic Surgeons
3. Premier Research Names Patrick Melvin as Senior Director, Clinical Trial Management
4. Product Development Timelines and Commercialization Strategy Are Focus of New Group at Premier Research
5. Premier Research Appoints Global Head of Human Resources
6. Premier Research Appoints Melissa Jones as Vice President, International Business Development
7. ARUP Laboratories and Premier Extend Contract for Reference Laboratory Testing Services
8. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
9. Cato Research and Neuland Laboratories Form Cato Research Neuland India, Ltd.
10. AMTs Cooperative Research and Development Agreement With NIH to Boost Production Capacity
11. Takedas Antibody Therapeutics Research Company, Takeda San Francisco, Inc. Appoints Mary Haak-Frendscho, Ph.D. as President and CSO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the ... major shareholders, Clean Technology Fund I, LP and Clean ... based venture capital funds which together hold approximately ... fully diluted, as converted basis), that they have entered ... equity holdings in Biorem to TUS Holdings Co. Ltd. ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
Breaking Biology Technology:
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
(Date:6/1/2016)... 2016 Favorable Government Initiatives Coupled ... Criminal Identification to Boost Global Biometrics System Market Through ... Research report, " Global Biometrics Market By Type, ... Opportunities, 2011 - 2021", the global biometrics market is ... account of growing security concerns across various end use ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
Breaking Biology News(10 mins):